Stada snaps up Nizoral brand in EMEA region

28 June 2018 - Deborah Wilkes


Stada Arzneimittel has acquired the rights to Johnson & Johnson's Nizoral (ketoconazole) anti-dandruff shampoo in Europe, the Middle East and Africa (EMEA) for an undisclosed sum.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: